Inactive Instrument

Mera Pharmaceuticals, Inc. Stock price Other OTC

Equities

MRPI

US58732R1032

Biotechnology & Medical Research

Sales 2010 289K Sales 2011 303K Capitalization 1.1M
Net income 2010 - Net income 2011 - EV / Sales 2010 5.85 x
Net Debt 2010 46K Net Debt 2011 295K EV / Sales 2011 4.59 x
P/E ratio 2010
-2.88 x
P/E ratio 2011
-4.98 x
Employees -
Yield 2010 *
-
Yield 2011
-
Free-Float 99.91%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
President 57 21-03-16
Members of the board TitleAgeSince
President 57 21-03-16
Director/Board Member 60 21-03-16
More insiders
Mera Pharmaceuticals, Inc. is a marine biotechnology company. The Company focuses on photobioreactor technology and owns intellectual property dedicated to the culture of microalgae for biofuel or nutriceutical production. The Company manufactures natural astaxanthin from Haematococcus pluvialis microalgae. Through its research and development, the Company has formulated AstaFactor, an astaxanthin supplement with antioxidant and anti-inflammatory activity, which is available in three formulations, such as rejuvenating formula, sports formula and salmon essentials, such as natural astaxanthin combined with a blend of fish and salmon oil. The Company also produces sea salt products, such as gourmet salt and nigari. The gourmet salt includes Hawaiian Furikake, Hawaiian Furikake refillable grinder, Kona Sea Salt, Kona Sea Salt flake salt case, Kona Sea Salt grinder and Kona Sea Salt grinder case. The Company offers nigari in sizes ranging from one gallon to 250 gallons.
More about the company
  1. Stock
  2. Equities
  3. Stock Mera Pharmaceuticals, Inc.
  4. Stock Mera Pharmaceuticals, Inc. - Other OTC